Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion. (PED-MR)
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion: a Multicenter Randomized Study Versus Standard Treatment.
The goal of this clinical investigation is to evaluate the effectiveness of ETD + standard treatment versus standard treatment only, on the improvement of the tympanic membrane retraction, up to 18 months after intervention in children aged ]8-17[ with posterior mesotympanic retraction and middle ear effusion.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Fabian BLANC, Dr
- 电话号码:+33 0668248182
- 邮箱:fabian-blanc@chu-montpellier.fr
学习地点
-
-
-
Montpellier、法国、34000
- Fabian BLANC
-
接触:
- Fabian BLANC
- 电话号码:+33 0668248182
- 邮箱:fabian-blanc@chu-montpellier.fr
-
-
APHM
-
Marseille、APHM、法国、13005
- Richard NICOLLAS
-
接触:
- Richard NICOLLAS, PhD
- 电话号码:+33 0491386709
- 邮箱:richard.nicollas@ap-hm.fr
-
-
APHP Hôpital Necker
-
Paris、APHP Hôpital Necker、法国、75006
- François SIMON
-
接触:
- François SIMON, PhD
- 电话号码:+33 0153104600
- 邮箱:f.simon@aphp.fr
-
-
APHP Hôpital Robert Debre
-
Paris、APHP Hôpital Robert Debre、法国、75019
- Thiery VAN DEN ABBEELE
-
接触:
- Thiery VAN DEN ABBEELE, PhD
- 电话号码:+33 0140032179
- 邮箱:thierry.van-den-abbeele@aphp.fr
-
副研究员:
- Natacha TEISSIER, PhD
-
副研究员:
- Charlotte BENOIT, Dr
-
副研究员:
- Emilie BOIS, Dr
-
-
HCL Hôptial Femme Mere Enfant
-
Lyon、HCL Hôptial Femme Mere Enfant、法国、69677
- Sonia AYARI
-
接触:
- Sonia AYARI, PhD
- 电话号码:+33 0427855729
- 邮箱:sonia.ayari-khalfallah@chu-lyon.fr
-
副研究员:
- Aurélie COUDERT, Dr
-
副研究员:
- Maxime TABEY, Dr
-
-
Hôpital Purpan
-
Toulouse、Hôpital Purpan、法国、40031
- Marie-Noël CALMELS
-
接触:
- Marie-Noël CALMES, PhD
- 电话号码:+33 0561779009
- 邮箱:calmels.mn@chu-toulouse.fr
-
副研究员:
- Blandine BALADI
-
副研究员:
- Yohan GALLOIS
-
-
Hôpital Salengro
-
Lille、Hôpital Salengro、法国、5900
- Philippine TOULEMONDE
-
接触:
- Philippine TOULEMONDE, Dr
- 电话号码:+33 0320446205
- 邮箱:philippine.toulemonde@chu-lille.fr
-
副研究员:
- Hugo DELERRY
-
副研究员:
- Christophe VINCENT
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Children aged strictly between 8 and 17 years of age
- Presenting a posterior mesotympanic retraction (grade II or III without adherence to the promontory from Sade's grade) with effusion
Exclusion Criteria:
- Weight strictly less than 20kg
- Down syndrome
- Craniosynostosis and other head and neck malformations
- History of skull base surgery
- History of skull fracture
- Failure to obtain consent
- Non-affiliation to a social security scheme
- Persons placed under legal protection
- Person participating in another research including a period of exclusion still in progress
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Eustachian tube dilation added to standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present. ETD involves using a transnasal balloon catheter, during general anesthesia, by the surgeon in charge of the patient. The device will be an Acclarent Aera 6x16 mm balloon, with a pressure set at 12 atm for 2 minutes in the eustachian tube. The manufacturer of the ETD device will organize a training session with hands-on on simulator, for all the principal investigators prior to the start of the study, to ensure homogenous intervention. |
Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical, coupled with the Acclarent Aera™ Eustachian Tube Balloon Dilation System. |
|
有源比较器:Standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present, during general anesthesia, by the surgeon in charge of the patient. Tube placement will be in the anterior or inferior part of the tympanic membrane. Different design and brand of tympanostomy tube exist and are used in the different centers, leading to putative slightly different outcomes in term of adverse events related to the tympanostomy tube and duration. To decrease the cohort's heterogeneity, we propose to utilize the same tympanostomy tube for all the patients included in the study (Shepard's tympanostomy tube). |
Medical device: Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Tympanic membrane retraction
大体时间:Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
The assessment of tympanic membrane retraction is treated as a survival variable. Tympanic membrane retraction will be blindly assessed by an adjudication committee, through recorded otoendoscopy, based on the Sade's classification (in grade 0, I, II, III, IV, or V). The delay will be calculated as the time from intervention to improvement in tympanic membrane retraction (event), to loss of follow up (censoring), or to the study endpoint (censoring). |
Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mesotympanic retractation
大体时间:6, 12 and 18 months
|
Mesotympanic retractation according to Sade's classification |
6, 12 and 18 months
|
|
Audiometry thresholds
大体时间:6, 12 and 18 months
|
Mean of the air-bone gap at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz |
6, 12 and 18 months
|
|
Tympanometry profile
大体时间:6, 12 and 18 months
|
Tympanometry profile (A, B or C) |
6, 12 and 18 months
|
|
The quality of life
大体时间:6, 12 and 18 months
|
Quality of Life measured through the OM-6 questionnaires |
6, 12 and 18 months
|
|
The quality of life
大体时间:6, 12 and 18 months
|
Quality of Life measured through the PedsQL™ 4.0 questionnaires |
6, 12 and 18 months
|
|
Adverse events in both arms
大体时间:during the first week
|
Occurrence of adverse events and serious events during the first week, coded according to MedDRA. |
during the first week
|
合作者和调查者
调查人员
- 首席研究员:Fabian BLANC, Dr、University Hospital, Montpellier
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.